Results for tag: "Optruma"

Optruma is a market within the Endocrine and Metabolic Disorders Drugs sector. It is comprised of drugs used to treat a variety of conditions, including diabetes, obesity, thyroid disorders, and other endocrine and metabolic disorders. These drugs are used to regulate hormones, control blood sugar levels, and reduce the risk of complications associated with these conditions. Optruma drugs are typically prescribed by endocrinologists and other healthcare professionals. The Optruma market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Other companies in the market include AstraZeneca, Boehringer Ingelheim, and Takeda Pharmaceuticals. Show Less Read more